Urocortin II (Human)
- Product Category: Peptides
Catalog #: 019-30
Size: 100 µg
Price: $198
Ala
A
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2
Dissolve in a small amount of DMSO or 60% acetonitrile in water with 0.1% TFA. Then dilute with water or any desired buffer.
For best results, rehydrate just before use.
After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Appearance: White powder
No results found.
Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P, Reis FM, Torres PB, et al. Obstet Gynecol. 2007;110(3):594-600.
Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
Muramatsu T, Inoue K, Iwasaki S, Yamauchi T, Hayashi T, Kiriike N. Pharmacol Biochem Behav. 2006;85(2):435-40.
High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
Florio P, Torricelli M, De falco G, et al. J Hypertens. 2006;24(9):1831-40.
Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies.
Torricelli M, Ignacchiti E, Giovannelli A, et al. Eur J Endocrinol. 2006;154(2):281-5.
High fetal urocortin levels at term and preterm labor.
Florio P, Torricelli M, Galleri L, et al. J Clin Endocrinol Metab. 2005;90(9):5361-5.
Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells.
Aggelidou E, Hillhouse EW, Grammatopoulos DK. Proc Natl Acad Sci USA. 2002;99(5):3300-5.